NCT06834269View on ClinicalTrials.gov

Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 2, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DEVICE

Transcranial magnetic stimulation (tSMS)

Transcranial static magnetic stimulation (tSMS) will be delivered simultaneously to both hemispheres, at the motor cortex (M1), via magnets housed in a helmet.

Trial Locations (1)

00128

RECRUITING

Fondazione Policlinico Campus Bio-Medico, Roma

All Listed Sponsors

lead

Campus Bio-Medico University

OTHER